BRISBANE, California, August 14, 2026, 13:19 EDT — U.S. cash markets traded during regular hours. Vera Therapeutics stock gained 9.7% to close at $31.70, having earlier reached $37.24 during the session.Kynam Capital reported a 4.01% stake, a decrease from 5.37% the previous year.Vera’s cash reserves of $499.2 million are enough to fund approximately 14.5 months…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.